Malin Corporation | MLC - Equity Capital And Reserves


Malin Corporation reported EUR193.2M in Equity Capital and Reserves for its fiscal semester ending in December of 2024.





Equity Capital And Reserves Change Date
Akebia Therapeutics USD 27.38M 5.24M Mar/2026
Alaunos Therapeutics USD 1.29M 865K Mar/2026
ALKERMES USD 1.75B 67.76M Mar/2026
Avita Medical AUD -16.65M 3.76M Dec/2025
Dianthus Therapeutics USD 1.2B 707.91M Mar/2026
Eurofins Scientific SE EUR 3.54B 114.8M Dec/2025
Ionis Pharmaceuticals USD 491.41M 2.32M Mar/2026
IQVIA Holdings USD 6.22B 282M Mar/2026
Lonza CHF 9.13B 513M Dec/2025
Malin Corporation EUR 193.2M 75M Dec/2024
Moderna USD 7.41B 1.24B Mar/2026
Organon & Co USD 903M 151M Mar/2026
Ovoca Bio EUR 1.26M 7.41M Jun/2025
Revvity USD 7.25B 125.54M Dec/2025
Tectonic Therapeutic USD 230.42M 20.91M Mar/2026
Viatris USD 14.66B 53.6M Mar/2026
Xeris Pharmaceuticals USD 13.01M 678K Mar/2026